
Releases
Ron Eastman Joins BRC Therapeutics Board to Steer Clinical Growth
With four decades of experience bridging pharmaceutical operations and high-stakes venture capital, veteran executive Ron Eastman has joined the board of directors at BRC Therapeutics. His appointment arrives as the Monterey-based firm prepares to advance its pipeline of multimodal cannabinoid-based treatments through critical clinical development stages.





.jpg)




















